[sandbox] K4D COVID-19 Resource Hub

Sort by: Date tagged Date published

49 - 72 of 1176

Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection

https://api.zotero.org/groups/2494380/items/K768F4BT?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 01/16/2021

Nosocomial Coronavirus Disease Outbreak Containment, Hanoi, Vietnam, March–April 2020 - Volume 27, Number 1—January 2021 - Emerging Infectious Diseases journal - CDC

https://api.zotero.org/groups/2494380/items/PS5MAB28?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 01/16/2021

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 – Preliminary report

https://api.zotero.org/groups/2494380/items/U4CZTRXT?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 01/16/2021

Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults

https://api.zotero.org/groups/2494380/items/92N23DYZ?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 01/16/2021

A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19

https://api.zotero.org/groups/2494380/items/MRPRFHAJ?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 01/16/2021

T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

https://api.zotero.org/groups/2494380/items/87VE3UPH?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 01/16/2021

Genetic mechanisms of critical illness in Covid-19

https://api.zotero.org/groups/2494380/items/X2QSHGRH?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020

Rapid triage for COVID-19 using routine clinical data for patients attending hospital: development and prospective validation of an artificial intelligence screening test

https://api.zotero.org/groups/2494380/items/ZQRQK8JB?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020

Global Mobility and the Threat of Pandemics: Evidence from Three Centuries

https://api.zotero.org/groups/2494380/items/CZKBXAL9?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020

Effect of internationally imported cases on internal spread of COVID-19: a mathematical modelling study

https://api.zotero.org/groups/2494380/items/T7R5USDY?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020

Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

https://api.zotero.org/groups/2494380/items/R8SKMFHB?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

https://api.zotero.org/groups/2494380/items/VBDBJIXY?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020

Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection

https://api.zotero.org/groups/2494380/items/HM4BKSP3?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

https://api.zotero.org/groups/2494380/items/Q5AD6SRX?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

https://api.zotero.org/groups/2494380/items/I7DNTRFA?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

https://api.zotero.org/groups/2494380/items/TBZPTNDS?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020

The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials

https://api.zotero.org/groups/2494380/items/LMLWLHY6?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020

Nigeria: Where Covid-19 Has Left Nigeria's Health System

https://api.zotero.org/groups/2494380/items/4Q3DCFMB?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020

Any Delay in Ending COVID Could Spur a Different Pandemic

https://api.zotero.org/groups/2494380/items/V7JVBWHH?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020

Facing up to long COVID

https://api.zotero.org/groups/2494380/items/DIT8BH3Y?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020

Coronavirus Vaccine Update With Anthony Fauci – December 11, 2020

https://api.zotero.org/groups/2494380/items/29NUQ987?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020

Reimagining India's health system: a Lancet Citizens’ Commission

https://api.zotero.org/groups/2494380/items/F67YVBQF?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020

The COVID-19 vaccines rush: participatory community engagement matters more than ever

https://api.zotero.org/groups/2494380/items/WY7E34NB?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020

Restricting Mobility Will Not Stop the Next Pandemic

https://api.zotero.org/groups/2494380/items/DU49ES98?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020

49 - 72 of 1176